Pharma & Biotech IP

With disruptive political and legislative change on the horizon at home and abroad, it has never been more important for European biopharma patent professionals to have a crystal-clear understanding of the changes shaping IP protection and value creation.

IAM’s third annual Pharma & Biotech IP event will provide cutting-edge legal and strategic insights to help practitioners safeguard and exploit their crucial life sciences assets.